Investor Relations
Q3 FY25 BD Earnings Conference Call
August 7, 2025 - 8:00 AM ET
About BD
BD is a global medical technology company that is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.
70,000+
BD Associates
190+
Countries Served
34B+
Devices Made Annually
$1B+
Annual R&D Spending
33,000+
Active Patents
As of Jan 24, 2023 • Annual Meeting of Shareholders Presentation
For complete information regarding our financials, see our periodic filings
Latest Financial Results
Q2 FY25
Quarter Ended Mar 31, 2025
$5.3B
Q2 2025 Total BD Revenue
$3.35
Q2 2025 Adjusted EPS*
Source: Q2 2025 Earning Press Release
* Non-GAAP Financial Measures. View full reconciliation in our Q2 earnings press release.
* Non-GAAP Financial Measures. View full reconciliation in our Q2 earnings press release.
For complete information regarding our financials, see our periodic filings
Latest Annual Filing
For Fiscal Year Ending Sep 30, 2024
Email Alerts
Sign up today and receive company updates straight to your inbox.
Together We Advance
Our Corporate Sustainability strategy—a four-pillar framework called Together We Advance—embraces the connections and interdependence between company health, planet health, community health and human health. Through this framework, we address the most relevant Corporate Sustainability issues for our business and stakeholders.
View Corporate Sustainability Efforts
IR Contacts
Corporate Office
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States
800.284.6845
Investor Relations
Becton, Dickinson and Company
800.284.6845
investor_relations@bd.com
Transfer Agent
Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3066
877.498.8861
computershare@computershare.com
https://www.computershare.com
Overnight Mail Address
150 Royall St., Suite 101
Canton, MA 02021